Regulation of gastric mucosal integrity by endogenous nitric oxide: interactions with prostanoids and sensory neuropeptides in the rat

British Journal of Pharmacology
B J WhittleS Moncada

Abstract

1. The interactions between nitric oxide (NO), prostacyclin and sensory neuropeptides in the maintenance of gastric mucosal integrity have been investigated in the anaesthetized rat. 2. Administration of either NG-monomethyl-L-arginine (L-NMMA) to inhibit endothelium-derived NO formation, indomethacin to inhibit prostanoid biosynthesis or chronic capsaicin pretreatment to deplete sensory neuropeptides, did not induce acute mucosal injury. 3. In capsaicin-pretreated rats, however, L-NMMA (12.5-100 mg kg-1 i.v.) dose-dependently induced acute mucosal damage, characterized as vasocongestion and haemorrhagic necrosis. The enatiomer D-NMMA (100 mg kg-1 i.v.) did not induce any detectable mucosal damage. 4. This mucosal injury induced by L-NMMA was inhibited by concurrent administration of L-arginine (300 mg kg-1 i.v.). 5. In indomethacin (5 mg kg-1 i.v.)-pretreated rats, L-NMMA also induced mucosal damage. Furthermore, following indomethacin administration in capsaicin-pretreated rats, L-NMMA induced widespread, severe haemorrhagic necrotic damage. 6. These findings suggest a role for endogenous NO formed from L-arginine, acting in concert with prostacyclin and sensory neuropeptides, in the modulation of gastric mucosal integrity.

References

Jul 1, 1985·Gastroenterology·E EkbladF Sundler
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D D ReesS Moncada
Dec 19, 1989·European Journal of Pharmacology·J M PiqueJ V Esplugues
Jun 1, 1989·British Journal of Pharmacology·J V EspluguesS Moncada
Dec 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·L J IgnarroG Chaudhuri
Dec 1, 1988·British Journal of Pharmacology·B J Whittle, J V Esplugues
Jul 15, 1988·Biochemical and Biophysical Research Communications·M KelmJ Schrader
Jun 30, 1988·Biochemical and Biophysical Research Communications·R M PalmerS Moncada
Jan 3, 1985·Nature·S D BrainI MacIntyre
Nov 1, 1983·Circulation Research·R F Furchgott

❮ Previous
Next ❯

Citations

May 1, 1994·Naunyn-Schmiedeberg's Archives of Pharmacology·M A Martinez-CuestaJ V Esplugues
Jan 1, 1995·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·L Franco
Mar 1, 1995·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·L Franco, G P Velo
Jan 1, 1992·Agents and Actions·N K Boughton-SmithB J Whittle
Mar 1, 1994·Digestive Diseases and Sciences·S J KonturekK Czarnobilski
Feb 1, 1994·Digestive Diseases and Sciences·F J AndrewsP E O'Brien
May 1, 1996·Digestive Diseases and Sciences·T CoskunH Kurtel
Oct 1, 1995·Digestive Diseases and Sciences·X LiuH Nawata
Jan 29, 2000·Biulleten' eksperimental'noĭ biologii i meditsiny·M G PshennikovaI Iu Malyshev
May 29, 2007·Journal of Gastroenterology·Hiroto YamadaToshikatsu Okumura
Dec 4, 1990·European Journal of Pharmacology·S R HughesS D Brain
May 30, 1991·European Journal of Pharmacology·B M PeskarB A Peskar
Aug 6, 1992·European Journal of Pharmacology·B J WhittleS Moncada
Feb 11, 1992·European Journal of Pharmacology·S J KonturekK Czarnobilski
Dec 15, 1992·European Journal of Pharmacology·S J KonturekB Slomiany
Oct 20, 1992·European Journal of Pharmacology·H P KuoP J Barnes
Jan 26, 1993·European Journal of Pharmacology·K TakeuchiS Okabe
Aug 24, 1993·European Journal of Pharmacology·A KirályY Taché
Jul 21, 1994·European Journal of Pharmacology·J G FerrazJ L Wallace
Apr 1, 1994·European Journal of Pharmacology·K Gyires
Apr 21, 1994·European Journal of Pharmacology·G ClementiM Amico-Roxas
Apr 24, 1995·European Journal of Pharmacology·D Lamarque, B J Whittle
Jun 23, 1995·European Journal of Pharmacology·J L WallaceS N Elliott
Sep 5, 1995·European Journal of Pharmacology·M BelvisiJ A Mitchell
Mar 1, 1992·Trends in Neurosciences·S R Vincent, B T Hope
Oct 6, 1995·European Journal of Pharmacology·B L Tepperman, B D Soper
Jan 1, 1995·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·L CuzzolinG Benoni
Apr 15, 1996·Environmental Toxicology and Pharmacology·M ItoY Suzuki

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.